CNTA Stock Price | Centessa Pharmaceuticals PLC ADR P/E, Revenue, EPS, & Forecasts

Centessa Pharmaceuticals PLC ADR • CNTA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Centessa Pharmaceuticals PLC ADR

Ticker

CNTA

Trading on

NASDAQ

ISIN

US1523091007

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Mario Alberto Accardi Ph.D.

Headquarters

1 Ashley Road, Altrincham, undefined, United Kingdom, WA14 2DT

Employees

118

Website

https://centessa.com

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Metrics

BasicAdvanced

Market cap

$6.12B

P/E ratio

EPS

-$1.46

Dividend Yield

0.00%

Beta

1.26

Forward P/E ratio

EBIDTA

$-207M

Ex dividend date

Price & volume

Market cap

$6.12B

Average daily volume

4.9M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

408

Price to book

11.59

Earnings

EPS

-$1.46

EPS estimate (current quarter)

-$0.38

EPS estimate (next quarter)

-$0.40

EBITDA

$-207M

Revenues (TTM)

$15M

Revenues per share (TTM)

$0.11

Technicals

Beta

1.26

52-week High

$40.26

52-week Low

$10.95

50-day moving average

$28.64

200-day moving average

$23.38

Short ratio

5.53

Short %

5.19%

Management effectiveness

ROE (TTM)

-42.55%

ROA (TTM)

-20.53%

Profit margin

0.00%

Gross profit margin

$15M

Operating margin

-1,384.61%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

155M

Float

97.9M

Insiders %

0.47%

Institutions %

96.10%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 11 analysts.

Average price target

$43.57

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.20

-$0.36

44.44%

Q1 • 25Beat

-$0.38

-$0.33

-15.26%

Q2 • 25Missed

-$0.41

-$0.39

-5.59%

Q3 • 25Missed

-$0.48

-$0.38

-24.90%

Q4 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-54.9M

-∞%

Q3 • 25

$0M

$-66.2M

-∞%

Q4 • 25

NaN%

20.54%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$448M

$147M

32.73%

Q3 • 25

$687M

$161M

23.36%

Q4 • 25

53.36%

9.48%

-28.61%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-58.3M

$61.9M

$3.4M

$-58.5M

Q3 • 25

$-55.8M

$-218M

$283M

$-55.8M

Q4 • 25

-4.30%

-452.12%

8,145.56%

-4.66%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Centessa Pharmaceuticals PLC ADR share?

Centessa Pharmaceuticals PLC ADR shares are currently traded for undefined per share.

How many shares does Centessa Pharmaceuticals PLC ADR have?

Centessa Pharmaceuticals PLC ADR currently has 155M shares.

Does Centessa Pharmaceuticals PLC ADR pay dividends?

No, Centessa Pharmaceuticals PLC ADR doesn't pay dividends.

What is Centessa Pharmaceuticals PLC ADR 52 week high?

Centessa Pharmaceuticals PLC ADR 52 week high is $40.26.

What is Centessa Pharmaceuticals PLC ADR 52 week low?

Centessa Pharmaceuticals PLC ADR 52 week low is $10.95.

What is the 200-day moving average of Centessa Pharmaceuticals PLC ADR?

Centessa Pharmaceuticals PLC ADR 200-day moving average is $23.38.

Who is Centessa Pharmaceuticals PLC ADR CEO?

The CEO of Centessa Pharmaceuticals PLC ADR is Dr. Mario Alberto Accardi Ph.D..

How many employees Centessa Pharmaceuticals PLC ADR has?

Centessa Pharmaceuticals PLC ADR has 118 employees.

What is the market cap of Centessa Pharmaceuticals PLC ADR?

The market cap of Centessa Pharmaceuticals PLC ADR is $6.12B.

What is the P/E of Centessa Pharmaceuticals PLC ADR?

The current P/E of Centessa Pharmaceuticals PLC ADR is null.

What is the EPS of Centessa Pharmaceuticals PLC ADR?

The EPS of Centessa Pharmaceuticals PLC ADR is -$1.46.

What is the PEG Ratio of Centessa Pharmaceuticals PLC ADR?

The PEG Ratio of Centessa Pharmaceuticals PLC ADR is null.

What do analysts say about Centessa Pharmaceuticals PLC ADR?

According to the analysts Centessa Pharmaceuticals PLC ADR is considered a buy.